Related references
Note: Only part of the references are listed.Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis
Harrison H. Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
K. W. Wyrwich et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Development of the Scalp Hair Assessment PRO™ measure for alopecia areata
Kw Wyrwich et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
Kathleen W. Wyrwich et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Alopecia areata: A multifactorial autoimmune condition
Teontor Simakou et al.
JOURNAL OF AUTOIMMUNITY (2019)
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
A. Jabbari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Alopecia areata is associated with impaired health-related quality of life: A survey of affected adults and children and their families
Lucy Y. Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Alopecia areata is a medical disease
Dorota Z. Korta et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Disease characteristics, clinical evaluation, and new perspectives on pathogenesis
Lauren C. Strazzulla et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Tofacitinib for the treatment of alopecia areata and variants in adolescents
Brittany G. Craiglow et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Alopecia areata
C. Herbert Pratt et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Alopecia areata and health-related quality of life: a systematic review and meta-analysis
F. Rencz et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review
Lucy Y. Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
Milene Kennedy Crispin et al.
JCI INSIGHT (2016)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
The autoimmune basis of alopecia areata: A comprehensive review
Naseeha Islam et al.
AUTOIMMUNITY REVIEWS (2015)
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
Ali Jabbari et al.
EBIOMEDICINE (2015)
Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
Brittany G. Craiglow et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
Alopecia areata investigational assessment guidelines - Part II
EA Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Share Paper
